Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:February 15, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:February 15, 2019Terminated
Condition(s):Bipolar DisorderLast Updated:January 17, 2024Recruiting
Condition(s):COVID; Vitamin D Deficiency; Coagulopathy; Disseminated Intravascular CoagulationLast Updated:December 27, 2021Withdrawn
Condition(s):Ischemic StrokeLast Updated:July 17, 2017Unknown status
Condition(s):Breast Cancer; AngiogenesisLast Updated:September 17, 2020Completed
Condition(s):Colorectal CancerLast Updated:November 18, 2015Unknown status
Condition(s):Coronary SyndromeLast Updated:February 28, 2024Completed
Condition(s):Acute Coronary SyndromeLast Updated:October 10, 2022Not yet recruiting
Condition(s):Diabetes Mellitus; Chronic PeriodontitisLast Updated:November 23, 2016Unknown status
Condition(s):HealthyLast Updated:January 8, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.